BioPharma Credit Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 565,930 | 0.0461% |
| Public Companies | 6,755,557 | 0.55% |
| Private Companies | 13,056,910 | 1.06% |
| General Public | 42,074,695 | 3.43% |
| Hedge Funds | 164,994,101 | 13.4% |
| Institutions | 1,000,635,952 | 81.5% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 164,994,101 | US$144.7m | 0.6% | 0.28% | |||
| 90,295,637 | US$79.2m | -9.33% | 0.02% | |||
| 75,917,376 | US$66.6m | -3.14% | 0.42% | |||
| 71,904,409 | US$63.0m | -2.5% | 63.57% | |||
| 52,366,107 | US$45.9m | -3.97% | 0.01% | |||
| 40,186,990 | US$35.2m | -1.14% | 0.01% | |||
| 39,621,885 | US$34.7m | -0.43% | 0.02% | |||
| 36,375,083 | US$31.9m | 40.2% | 0.02% | |||
| 32,121,234 | US$28.2m | 0.92% | 0.52% | |||
| 31,742,041 | US$27.8m | 7.51% | 0.17% | |||
| 25,506,223 | US$22.4m | -5.17% | 0.01% | |||
| 24,876,196 | US$21.8m | -21% | 1.36% | |||
| 24,029,371 | US$21.1m | 0% | 0.05% | |||
| 23,975,227 | US$21.0m | 6.96% | 0.86% | |||
| 23,873,523 | US$20.9m | -7.26% | 0.01% | |||
| 19,799,186 | US$17.4m | 2.73% | 0.18% | |||
| 19,345,711 | US$17.0m | -2.78% | 0.01% | |||
| 19,067,072 | US$16.7m | 1.49% | 0.24% | |||
| 18,300,906 | US$16.0m | 9.72% | no data | |||
| 13,954,252 | US$12.2m | -1.59% | 0.19% | |||
| 13,885,432 | US$12.2m | -3.74% | 0.08% | |||
| 12,800,000 | US$11.2m | 0% | 0.2% | |||
| 12,494,259 | US$11.0m | 0% | 5.06% | |||
| 12,210,123 | US$10.7m | 0.44% | 1.65% | |||
| 10,655,342 | US$9.3m | 7.84% | 0.44% |